| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 0IVD6ASY0W |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | Neural cell adhesion molecule 1 binding agent | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Wilms Tumor | 2 | D009396 | ClinicalTrials |
| Rhabdomyosarcoma | 2 | D012208 | ClinicalTrials |
| Leukemia | 2 | D007938 | ClinicalTrials |
| Neuroblastoma | 2 | D009447 | ClinicalTrials |
| Neurilemmoma | 2 | D009442 | ClinicalTrials |
| Sarcoma, Synovial | 2 | D013584 | ClinicalTrials |
| Small Cell Lung Carcinoma | 1 | D055752 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1008106-64-6 |
| ChEMBL | CHEMBL1743037 |
| FDA SRS | 0IVD6ASY0W |
| Guide to Pharmacology | 7431 |
CONTENTS